Finance Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 BeatNovember 17, 20250 GeneDx Holdings Corp. (NASDAQ:WGS) is without doubt one of the greatest digital well being shares to purchase now. On October…
Finance Guggenheim expects Fed to cut rates about every quarter in 2025January 21, 20250 By Divya Chowdhury and Bansari Mayur Kamdar DAVOS, Switzerland (Reuters) – Guggenheim Companions’ chief funding officer forecast on Monday that…
